rdf:type |
|
lifeskim:mentions |
umls-concept:C0007137,
umls-concept:C0014852,
umls-concept:C0017262,
umls-concept:C0024204,
umls-concept:C0027627,
umls-concept:C0033684,
umls-concept:C0185117,
umls-concept:C0286983,
umls-concept:C0812444,
umls-concept:C1413246,
umls-concept:C1705784,
umls-concept:C2911684
|
pubmed:issue |
7-8
|
pubmed:dateCreated |
1999-4-13
|
pubmed:abstractText |
Although the mechanisms of action of the transmembrane superfamilies, motility-related protein-1 (MRP-1/CD9) and KAI1/CD82, are not well known, they are reported to suppress the metastasis of several kinds of cancers. The suppression of cell motility by MRP-1/CD9 may cause suppression of the metastasis. As we could not find any reports concerning the expression of MRP-1/CD9 and KAI1/CD82 in oesophageal cancers we investigated their expression in oesophageal specimens. We conducted immunohistochemical staining for MRP1/CD9 against 108 cases of oesophageal squamous cell carcinoma using anti-MRP-1/CD9 monoclonal antibody M31-15, and for KAI1/CD82 against 104 cases using anti-KAI1/CD82 monoclonal antibody C33. To investigate the gradual expression of MRP-1/CD9 and KAI1/CD82, 24 oesophageal dysplasias were immunohistochemically stained using the same method and then investigated. The expression of both MRP-1/CD9 and KAI1/CD82 were positive on the cell membranes of normal oesophageal epithelial cells, but reduced or negative in the cancer cells. Reduced MRP-1/CD9 expressions significantly correlated to tumour depth (P = 0.0009). We found a significantly greater number of reduced or negative expression of MRP-1/CD9 and KAI1/CD82 in lymph node metastatic cases (P = 0.0003 and P= 0.0129, respectively), but not in distant metastatic cases. The 5-year survival rate of MRP-1/CD9-negative and reduced patients was significantly worse than those of positive patients (n = 108, curative cases, RO). Few cases remained KAI1/CD82-positive (9.6%; 10/104) in oesophageal cancer. Twenty (83.3%) and twenty-two (91.7%) cases out of 24 dysplasias were defined as KAI1/CD82-positive and MRP1/CD9-positive, respectively. The decrease in MRP-1/CD9 and KAI1/CD82 expression may facilitate lymph node metastasis in oesophageal squamous cell carcinomas. Knowing the status of the expression of MRP-1/CD9 appears helpful in predicting the prognosis for each patient.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/10098753-1720807,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10098753-1840589,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10098753-2455569,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10098753-7664290,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10098753-7754374,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10098753-7790364,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10098753-7876316,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10098753-8478605,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10098753-8521390,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10098753-8620488,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10098753-8813131,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10098753-8909232,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10098753-9205061
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD82,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD9,
http://linkedlifedata.com/resource/pubmed/chemical/CD82 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/CD9 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0007-0920
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
79
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1168-73
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10098753-Adult,
pubmed-meshheading:10098753-Aged,
pubmed-meshheading:10098753-Aged, 80 and over,
pubmed-meshheading:10098753-Antigens, CD,
pubmed-meshheading:10098753-Antigens, CD82,
pubmed-meshheading:10098753-Antigens, CD9,
pubmed-meshheading:10098753-Carcinoma, Squamous Cell,
pubmed-meshheading:10098753-Esophageal Neoplasms,
pubmed-meshheading:10098753-Female,
pubmed-meshheading:10098753-Humans,
pubmed-meshheading:10098753-Immunohistochemistry,
pubmed-meshheading:10098753-Lymphatic Metastasis,
pubmed-meshheading:10098753-Male,
pubmed-meshheading:10098753-Membrane Glycoproteins,
pubmed-meshheading:10098753-Middle Aged,
pubmed-meshheading:10098753-Neoplasm Proteins,
pubmed-meshheading:10098753-Proto-Oncogene Proteins
|
pubmed:year |
1999
|
pubmed:articleTitle |
Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
|
pubmed:affiliation |
Department of Surgery and Surgical Basic Science, Graduate School of Medicine, Kyoto University, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|